Neratinib +/- temsirolimus in HER2-mutant lung cancers: An international, randomized phase II study Meeting Abstract
| Authors: | Gandhi, L.; Besse, B.; Mazieres, J.; Waciar, S.; Cortot, A.; Barlesi, F.; Quoix, E.; Otterson, G.; Ettinger, D.; Horn, L.; Moro-Sibilot, D.; Socinski, M.; Gold, K.; Gray, J.; Oton, A.; Heist, R. S.; Costa, D.; McCulloch, L.; Bebchuk, J.; Bryce, R.; Kris, M. |
| Abstract Title: | Neratinib +/- temsirolimus in HER2-mutant lung cancers: An international, randomized phase II study |
| Meeting Title: | IASLC 17th World Conference on Lung Cancer |
| Keywords: | lung cancer; temsirolimus; neratinib; nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 12 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2016 Dec 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | S358 |
| End Page: | S359 |
| Language: | English |
| ACCESSION: | WOS:000413055800381 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2016.11.398 |
| Notes: | Meeting Abstract: MA04.02 -- Source: Wos |
